Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2Philip J Mease, Apinya Lertratanakul, Jaclyn K Anderson, Kim Papp, Filip Van den Bosch, Shigeyoshi Tsuji, Eva Dokoupilova, Mauro Keiserman, Xin Wang, Sheng Zhong, Reva M McCaskill, Patrick Zueger, Aileen L Pangan, William Tillett
3 December 2020
Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trialsPhilip J Mease, Philip S Helliwell, Kasper Fjellhaugen Hjuler, Kyle Raymond, Iain McInnes
26 October 2020
Systemic evaluation of the relationship between psoriasis, psoriatic arthritis and osteoporosis: observational and Mendelian randomisation studyJiangwei Xia, Shu-Yang Xie, Ke-Qi Liu, Lin Xu, Pian-Pian Zhao, Si-Rui Gai, Peng-Lin Guan, Jin-Qiu Zhao, Yan-Ping Zhu, Lam C Tsoi, Philip E Stuart, Rajan P Nair, Han-Qi Yang, Yu-Ting Liao, Kaijing MaoSee the full list of authors
31 July 2020
Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52Josef S Smolen, Philip Mease, Hasan Tahir, Hendrik Schulze-Koops, Inmaculada de la Torre, Lingnan Li, Maja Hojnik, Christophe Sapin, Masato Okada, Roberto Caporali, Jordi Gratacós, Philippe Goupille, Soyi Liu Leage, Sreekumar Pillai, Peter Nash
13 July 2020
DAPSA, carotid plaque and cardiovascular events in psoriatic arthritis: a longitudinal studySteven Ho Man Lam, Isaac T Cheng, Edmund K Li, Priscilla Wong, Jolie Lee, Ronald Man-Lung Yip, Cheuk-Wan Yim, Shirley K Ying, Martin Li, Tena K Li, Alex Pui-Wai Lee, Lai-Shan Tam
31 July 2020
Normal human enthesis harbours conventional CD4+ and CD8+ T cells with regulatory features and inducible IL-17A and TNF expressionAbdulla Watad, Hannah Rowe, Tobias Russell, Qiao Zhou, Lisa K Anderson, Almas Khan, Robert Dunsmuir, Peter Loughenbury, Vishal Borse, Abhay Rao, Peter A Millner, Nicola Luigi Bragazzi, Howard Amital, Richard Cuhtbert, Miriam WittmannSee the full list of authors
13 May 2020
Mixed methods study of clinicians’ perspectives on barriers to implementation of treat to target in psoriatic arthritisEmma Dures, Julie Taylor, Sasha Shepperd, Sandeep Mukherjee, Joanna Robson, Ivo Vlaev, Nicola Walsh, Laura C Coates
18 May 2020
Novel and reliable DACTylitis glObal Sonographic (DACTOS) score in psoriatic arthritisAlen Zabotti, Garifallia Sakellariou, Ilaria Tinazzi, Luca Idolazzi, Alberto Batticciotto, Marco Canzoni, Greta Carrara, Orazio De Lucia, Fabiana Figus, Nicolò Girolimetto, Pierluigi Macchioni, Rebecca McConnell, Niccolò Possemato, Annamaria Iagnocco
19 May 2020
Differences in the serum metabolome and lipidome identify potential biomarkers for seronegative rheumatoid arthritis versus psoriatic arthritisMargarida Souto-Carneiro, Lilla Tóth, Rouven Behnisch, Konstantin Urbach, Karel D Klika, Rui A Carvalho, Hanns-Martin Lorenz
20 February 2020
GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritisElsa Vieira-Sousa, Pedro Alves, Ana M Rodrigues, Filipa Teixeira, Jose Tavares-Costa, Alexandra Bernardo, Sofia Pimenta, Fernando M Pimentel-Santos, João Lagoas Gomes, Renata Aguiar, Patrícia Pinto, Taciana Videira, Cristina Catita, Helena Santos, Joana BorgesSee the full list of authors
19 March 2020